News

Receiving a “Stand Up to Cancer Day” email gave me the strength to support a friend through her darkest cancer days.
Dr. Josh Sabari and Max Doppelt explore challenges in trial enrollment and the potential of emerging therapies to offer hope ...
For patients with advanced non-small cell lung cancer who progressed on two or more prior regimens, THIO with Libtayo ...
That is what standing up to cancer means to me: not just surviving, but living fully, deeply, and purposefully, showing the ...
Chemotherapy can trigger early menopause, while strategies and new data on pausing therapy may help women protect fertility ...
This guide for newly diagnosed patients provides key information to help you understand your options and have informed conversations with your oncologist.
Early-stage gynecologic cancer is confined to its original site and often treatable; diagnosis, surgery, and new therapies improve outcomes.
Dr. Thomas Jankowski explained that THIO, a telomerase inhibitor, is being studied with Libtayo to help overcome resistance in advanced lung cancer.